Skip to search formSkip to main contentSkip to account menu

BCL-2 Inhibitor [EPC]

Known as: B-Cell Lymphoma-2 Inhibitor, B-Cell Lymphoma-2 Protein Inhibitor, Bcl 2 Inhibitor 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Favorable Clinical Outcome in Cholangiocellular Carcinoma is Associated with the CC Genotype in the GNB3 825 C>T SNP – a Putative Novel Independent Prognostic Marker
Background/Aims: Cholangiocellular carcinoma (CCA) has a devastating prognosis. While markers enabling a precise prediction of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)